Quality of Life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: results of the APPRECIA trial

In APPRECIA trial, Crohn's disease (CD) patients undergoing intestinal resection were randomized to postoperative adalimumab (ADA) or azathioprine (AZA).

from Gastroenterology via xlomafota13 on Inoreader http://bit.ly/2TT4I37
via IFTTT